Research Daily Summary
Research Daily Summary: What Happened on November 14, 2026
Blood marker distinguishes advanced CTE in preliminary study
The findings point to a possible way to detect severe disease, but the marker is not validated for CTE diagnosis.
Today in brief
Washington University researchers found that blood levels of eMTBR-tau243 rose with CTE severity and separated advanced cases from controls with an AUC of 0.97.1 The preliminary study found lower accuracy for stage I CTE, and the marker alone cannot distinguish CTE from Alzheimer’s disease.1